Be the first to see our brand new agenda for Microbiome Drug Development 2018. Focusing exclusively on the development and commercialization of microbiome-based therapeutics, with case studies from target discovery all the way through to clinical trial development, manufacturing and beyond – download your copy now to see what will be discussed.
“Great speakers, great topics, and good engagement. I found it one of the best meetings on the microbiome that I’ve been to in a few years.”
View the complete agenda and speaker list here.